Using the aggressive DLBCL xenograft model (WSU DLCL2) and preclinical animal models of stem cell humanized (HSC) NSG mice [38], we have previously reported the mechanisms leading to CD20-TCB mediated in vitro tumor cell killing and its efficacy in vivo [7]. This evidence concerns the gene PKM and neoplasm.